Calcium-Activated Potassium Channels Inhibition in Autonomically Stimulated Human Atrial Myocytes by Celotto, C. et al.
Calcium-Activated Potassium Channels Inhibition in Autonomically Stimulated
Human Atrial Myocytes
Chiara Celotto1,3, Carlos Sánchez1,2, Pablo Laguna1,3, Esther Pueyo1,3
1 Aragon Institute of Engineering Research, Univ. Zaragoza, Spain
2 Defence University Centre, General Military Academy, Zaragoza, Spain
3 CIBER in Bioengineering, Biomaterials and Nanomedicine, Zaragoza, Spain
Abstract
The autonomic nervous system has been reported to play
a major role in the generation and maintenance of atrial
fibrillation. Various investigations have suggested small-
conductance calcium-activated potassium (SK) channels
as potential targets for more effective pharmacological
therapies. In this study, we used in silico modeling and
simulation to investigate the effects of SK channel inhibi-
tion on the action potential (AP) of autonomically stimu-
lated human atrial cardiomyocytes. The Grandi AP model,
with a new formulation for the ISK current, was used
to represent human atrial electrophysiology. Choliner-
gic stimulation by different concentrations of acetylcholine
(ACh) hyperpolarized the AP and shortened the AP dura-
tion (APD) in a dose-dependent manner, with up to 7 mV
resting membrane potential elevation and >200 ms APD
shortening for 1 µM ACh at 1 Hz pacing frequency. Ad-
ditional β-adrenergic stimulation by 1 µM Isoproterenol
(Iso) partially attenuated the effects of cholinergic stim-
ulation by prolonging the APD by 41.6%. ISK inhibition
was able to reverse the effects of cholinergic activation,
but only for moderate ACh doses and when combined with
1 µM Iso, leading to 58.3% prolongation of the AP stim-
ulated with 0.01 µM ACh. In conclusion, ISK inhibition
combined with β-adrenergic stimulation can be effective in
antagonizing cholinergic effects on human atrial myocytes.
1. Introduction
Atrial fibrillation (AF) is the most common sustained
arrhythmia worldwide, but the efficacy of current anti-AF
therapies is far from optimal. The autonomic nervous sys-
tem (ANS) has been reported to play a major role in the
generation and maintenance of atrial fibrillation [1]. Clin-
ical and experimental studies have reported fluctuations in
both sympathetic and parasympathetic nervous systems in-
ducing atrial electrophysiological alterations that can po-
tentially result in atrial tachyarrythmias and AF [2].
Acetylcholine (ACh), the parasympathetic neurotrans-
mitter, has been shown to shorten the action potential
(AP) duration (APD) of atrial cells by activating the ACh-
activated potassium repolarizing current (IKACh). Further-
more, ACh is rapidly broken down at its release site by
acetylcholinesterase, which facilitates large regional vari-
ation in ACh concentration [3]. The shortened APD com-
bined with the spatially heterogeneous ACh distribution in-
creases susceptibility to AF [1].
Recently, various in vivo and ex vivo investigations
have suggested inhibition of small-conductance calcium-
activated potassium (SK) channels as a potential therapeu-
tic option for AF treatment [3]. Inhibition of SK channels
has anti-arrhythmic effects by prolonging atrial APD and
increasing atrial effective refractory period [4]. An advan-
tage of pharmacologically targetting SK channels is that
they are preferentially expressed in the atria as compared
to the ventricles [1, 5], thus they might constitute a rela-
tively atrial-selective target. Further studies are needed to
confirm the anti-arrhythmic benefits of SK channel inhi-
bition in both short- and long-lasting AF, as AF-induced
remodeling has been suggested to be associated with ISK
downregulation [1, 6].
In this work in silico modeling and simulation was used
to investigate the effects of SK channel inhibition in adren-
ergically and cholinergically stimulated human atrial car-
diomyocytes. We hypothesize that SK inhibition, individ-
ually or in combination with adrenergic stimulation, might
act to counteract the very prominent APD shortening in-
duced by cholinergic stimulation in the human atria.
2. Methods
2.1. Human atrial cell model with choliner-
gic and adrenergic effects
The Grandi AP computational model, built based on a
wide set of experimental data from human atrial cardiomy-
ocytes, was used to represent human atrial electrophysiol-
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ogy [7].
Parasympathetic effects were described by including
IKACh, which was defined as in Voigt et al., but corrected
with the experimental data from Koumi et al. [7].Sympa-
thetic stimulation of the heart activates the β-adrenergic
signaling cascade by triggering PKA-dependent phospho-
rylation of different cellular substrates, namely ICa, IKs,
IKur, PLN-SERCA2a, RyR2, troponin calcium affinity,
and Na/K-ATPase. In the Grandi AP model, β-adrenergic
effects were modeled similarly to the model developed by
Shannon et al. [7].
2.2. Human atrial SK current
A new formulation for the ISK current, based on exper-
imental evidence [8], was introduced into the Grandi AP
model. The Grandi model with the added current is con-
sidered, in this study, as the reference AP model. ISK was
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where gSK is the conductance of I SK, EK is the Nernst po-
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and τ f = 3 ms is the time constant associated with the acti-
vation gate f. Since the model by Engel et al. was built for
neurons and not for cardiac cells, the conductance gSK was
adapted so that the contribution of the ISK current was con-
sistent with the results reported from experiments in iso-
lated atrial myocytes and atrial trabeculae strips from pa-
tients in sinus rhythm, where SK channel block increased
APD90 by around 20% [3].
2.3. Simulation protocols
The impact of cholinergic stimulation on AP was inves-
tigated at the following ACh concentrations: 0.001, 0,01,
0,1 and 1 µM. Physiological ACh doses have been reported
to be in the range 0.01 – 0.1 µM [11]. The effects of
β-adrenergic stimulation were tested on top of choliner-
gic effects by adding an Isoproterenol (Iso) dose of 1 µM.
ISK block was simulated on cholinergically stimulated my-
ocytes as well as on cholinergically and β-adrenergically





4) ACh + ISK block
5) ACh + Iso
6) ACh + Iso + ISK block
Pacing was applied at a fixed cycle length (CL) for 5
minutes to reach steady state. To investigate frequency-
dependent effects, CLs varying from 500 to 2000 ms were
tested. APD90 was measured at 90% repolarization of the
AP.
Figure 1. Simulated effects of ACh (at doses of 0.01 and
0.1 µM) (a), Iso (at a 1 µM dose) (b) and SK channel
block (c) on human atrial cardiomyocytes paced at a CL
of 1000 ms. Simulated results are compared with experi-
mental data reported in [9] (a), [10] (b) and [3] (c).
3. Results
3.1. Individual effects of cholinergic, β-
adrenergic and SK channel block
ACh hyperpolarized the resting membrane potential and
shortened the APD90 in a dose-dependent manner, as can
be observed in Figure 1 a), which shows steady-state APs
for control as well as after application of ACh at concen-
trations of 0.01 and 0.1 µM at a CL of 1000 ms. These
results are in agreement with reported experimental obser-
vations [9], which are shown in Figure 1 a) insets, to fa-
cilitate comparison. For the highest tested ACh dose of 1
µM, resting membrane potential was decreased by 7 mV
and APD90 was shortened over 200 ms (results not shown
in figure).
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The effects of β-adrenergic stimulation by 1 µM Iso
were less prominent than cholinergic effects. As shown
in Figure 1 b), 1 µM Iso led to slight AP hyperpolarization
and APD90 prolongation. Similar effects were reported in
some experimental studies [10], which are shown in the
inset of the same panel.
SK channel block reduced the repolarization current,
leading to prolongation of AP phase 3 and thus increas-
ing APD90. This is illustrated in Figure 1 c), together with
reported experimental evidence [3] to confirm the ability
of the in silico model to reproduce ISK inhibition action on
AP.
3.2. Frequency-dependence of cholinergic,
β-adrenergic and SK channel block
Under control conditions, APD90 showed a strong fre-
quency dependence, with values varying from 178 ms for
a CL of 500 ms to 289 ms for a CL of 2000 ms. Thus,
autonomic and SK block actions were analyzed in relative
terms, i.e. expressed as percentage with respect to the con-
trol case for each given CL.
The relative APD90 shortening caused by ACh increased
with CL. For an ACh dose of 1 µM, APD90 was shortened
by 82.7% for a CL of 500 ms up to 88.7 % for a CL of 2000
ms. For an ACh dose of 0.01 µM, the percentages of APD
shortening ranged from 21.7% to 36% for CL varying from
500 to 2000 ms.
APD90 changes induced by application of 1 µM Iso were
also frequency-dependent, with APD90 prolongation per-
centages covering from 20% for a CL of 500 ms to 33%
for a CL of 2000 ms.
SK channel block caused frequency-dependent APD90
changes, but in this case the effect was stronger for shorter
CLs. APD90 was prolonged by 40% for CL = 500 ms, 24%
for CL = 1000 ms and 23% for CL = 2000 ms.
3.3. Combined cholinergic, β-adrenergic
and SK channel block
Figure 2 presents results corresponding to cholinergic
stimulation applied individually as well as in combination
with β-adrenergic stimulation and/or ISK block, for a fixed
CL of 1000 ms. Adrenergic stimulation by 1 µM Iso par-
tially attenuated the effects of cholinergic stimulation, but
only when ACh doses were below 0.01 µM. For cholin-
ergically stimulated cardiomyoctes with the lowest phys-
iological ACh dose of 0.01 µM, Iso prolonged APD90 by
recovering 42% of the lost APD value, this being in line
with experimentally reported results [11]. ISK block was
able to partially counteract the effects of cholinergic ac-
tivation but, again, only for moderate ACh doses (by re-
covering 21% of the lost APD value under 0.01 µM ACh),
while for the upper physiological limit of 0.1 µM Ach, the
Figure 2. APD90 vs ACh dose for human atrial my-
ocytes paced a CL of 1000 ms at four different tested sce-
narios comprising cholinergic stimulation individually and
in combination with β-adrenergic stimulation and/or ISK
block.
effects were negligible. The combination of SK block and
1 µM Iso potentiated the individual actions for moderate
cholinergic stimulation. For an ACh dose of 0.01 µM, the
combined action led to a recovery as much as 58% of the
lost APD, while for the upper physiological limit of 0.1
µM ACh, the effect was the same as due solely to Iso.
Figure 3 presents absolute (top panel) and relative (bot-
tom panel) changes, expressed as % recovery of the
lost APD, induced by combined cholinergic, β-adrenergic
and/or ISK block actions for a fixed ACh dose of 0.01 µM
and CL varying from 500 to 2000 ms. Relative APD90 pro-
longation by Iso and Iso + SK block applied to of choliner-
gically stimulated myocytes was relatively constant upon
CL variations, whereas isolated SK block led to relative
APD90 prolongations remarkably stronger for short CLs
(60% prolongation for CL = 500 ms, 13% for CL = 2000
ms).
4. Discussion and conclusion
This study has investigated the effects of SK channel
inhibition on autonomically stimulated human atrial car-
diomyocytes. For myocytes under moderate cholinergic
stimulation, corresponding to application of a physiologi-
cal ACh dose of 0.01 µM/L, ISK inhibition has shown the
ability to partially antagonize cholinergic effects, partic-
uarly when in combination with β-adrenergic stimulation.
Those effects were more manifest for high pacing frequen-
cies, above 1 Hz, whereas a remarkable reduction in its
effectivenes was seen for frequencies around 0.5 Hz. For
highly cholinergically stimulated myocytes, corresponding
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Figure 3. Top panel: represents, for an ACh dose of 0.01
µM, APD90 vs CL for the different simulated scenarios.
Bottom panel: Percentage of APD90 prolongation recov-
ery calculated with respect to the difference between the
APD90 of the control case (100%) and ACh only (zero ref-
erence) vs the CL for the different simulated scenarios.
to application of a physiological ACh dose of 0.1 µM/L,
the effects of SK inhibition were negligible. Thus, the re-
sults from this study do not support SK channel block as an
option always valid to counteract the effects of cholinergic
stimulation, although they confirm the ability of SK chan-
nel block to potentiate the effects of β-adrenergic stimu-
lation, particularly for low frequencies where the isolated
effect of the SK block was weaker.
Further studies, including tissue simulations, will help
to shed more light and elucidate the mechanisms un-
derlying the experimentally reported beneficial effects of
SK channel block in human atria, particularly following
cholinergic and/or β-adrenergic stimulation. Of note, this
study focused on patients in sinus rhythm, where the SK
current has been reported to be more highly expressed than
in AF remodelling [6]. Subsequent investigations could
expand this research to assess SK channel inhibition ef-
fects on remodeled atria from chronic AF patients.
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